NCT04019626View on ClinicalTrials.gov

A Study to Assess Tobacco-related Biomarkers of Exposure in Smokers Using myBlu E-cigarettes

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Healthy Volunteers
Interventions
OTHER

Continue-smoking

Ad-libitum use of subjects' usual brand combustible cigarette

OTHER

myblu Tobacco 2.5%

Ad-libitum use of myblu e-cigarette with Tobacco flavor 2.5% nicotine

OTHER

myblu Tobacco 4.0%

Ad-libitum use of myblu e-cigarette with Tobacco flavor 4.0% nicotine

OTHER

myblu Honeymoon 2.5%

Ad-libitum use of myblu e-cigarette with Honeymoon flavor 2.5% nicotine

OTHER

myblu Honeymoon 4.0%

Ad-libitum use of myblu e-cigarette with Honeymoon flavor 4.0% nicotine

OTHER

JUUL 5%

Ad-libitum use of JUUL 5% e-cigarette

Trial Locations (1)

68502

Celerion, Lincoln

All Listed Sponsors
lead

Fontem Ventures BV

INDUSTRY

NCT04019626 - A Study to Assess Tobacco-related Biomarkers of Exposure in Smokers Using myBlu E-cigarettes | Biotech Hunter | Biotech Hunter